Cancer immunotherapy hla a1 antigen. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy27

T-Lymphocytes, Cytotoxic Dendritic Cells T-Lymphocytes CD8-Positive T-Lymphocytes Cell Line, Tumor Lymphocytes, Tumor-Infiltrating CD4-Positive T-Lymphocytes Tumor Cells, Cultured Killer Cells, Natural T-Lymphocytes, Regulatory Antigen-Presenting Cells Cytokine-Induced Killer Cells Cell Line Cells, Cultured Leukocytes, Mononuclear Lymph Nodes T-Lymphocyte Subsets K562 Cells B-Lymphocytes Spleen Killer Cells, Lymphokine-Activated Clone Cells Lymphocytes Th1 Cells Myeloid Cells Pollen Immune System

Organisms9

Mice, Inbred C57BL Mice, Inbred BALB C Mice, Transgenic Mice, Nude Mice, SCID Adenoviridae Mice, Knockout Lentivirus Mice, Inbred C3H

Diseases30

Neoplasms Melanoma, Experimental Melanoma Prostatic Neoplasms Neoplasms, Experimental Lung Neoplasms Colonic Neoplasms Ovarian Neoplasms Neoplasm Metastasis Breast Neoplasms Rhinitis, Allergic, Seasonal Skin Neoplasms Stomach Neoplasms Disease Models, Animal Pancreatic Neoplasms Colorectal Neoplasms Neoplasm Invasiveness Adenocarcinoma Genetic Predisposition to Disease Urinary Bladder Neoplasms Disease Progression Uterine Cervical Neoplasms Lymphoma Kidney Neoplasms Carcinoma, Squamous Cell Fibrosarcoma Carcinoma Hypersensitivity Carcinoma, Non-Small-Cell Lung Neoplasm Recurrence, Local

Chemicals and Drugs96

Antigens, Neoplasm Cancer Vaccines HLA Antigens Antigens Antigens, Bacterial Antigens, Surface HLA-A2 Antigen Antibodies, Monoclonal HLA-A Antigens Antigens, Viral Antigens, CD HLA-A24 Antigen Neoplasm Proteins Epitopes Interferon-gamma Epitopes, T-Lymphocyte Receptors, Antigen, T-Cell Carcinoembryonic Antigen CTLA-4 Antigen Histocompatibility Antigens Class I Antigens, Tumor-Associated, Carbohydrate HLA-DR Antigens Interleukin-2 gp100 Melanoma Antigen Antigens, Protozoan MART-1 Antigen Adjuvants, Immunologic Vaccines, Subunit Antigens, Polyomavirus Transforming Antibodies, Neoplasm Antineoplastic Agents Receptors, Antigen Antigens, CD80 Prostate-Specific Antigen Antigens, CD3 H-2 Antigens Antigens, Fungal HLA-B Antigens Histocompatibility Antigens Class II Vaccines, DNA Cytokines Antigens, CD40 Melanoma-Specific Antigens Antigens, Helminth Peptide Fragments Tumor Markers, Biological Peptides RNA, Messenger Membrane Glycoproteins Recombinant Proteins Immunoglobulin G Antibodies Histocompatibility Antigens Antibodies, Bispecific BCG Vaccine Allergens Antigens, Viral, Tumor Recombinant Fusion Proteins HLA-DQ Antigens Interleukin-12 Antigens, Differentiation Mucin-1 Proliferating Cell Nuclear Antigen Antigens, CD8 HLA-D Antigens Receptor, erbB-2 Granulocyte-Macrophage Colony-Stimulating Factor Single-Chain Antibodies Ovalbumin Vaccines, Synthetic Programmed Cell Death 1 Receptor Antigens, CD137 Papillomavirus E7 Proteins Immunoglobulin E Receptors, Antigen, T-Cell, gamma-delta Receptors, Antigen, B-Cell Tissue Extracts O Antigens Membrane Proteins 4-1BB Ligand Immunologic Factors Antigens, CD15 GPI-Linked Proteins Antigens, Plant Bee Venoms Immunoglobulin Fragments Antigens, CD4 V-Set Domain-Containing T-Cell Activation Inhibitor 1 HLA-C Antigens Antibodies, Blocking Antigens, CD45 Interleukin-15 Blood Group Antigens HLA-A1 Antigen Autoantigens Hepatitis B Surface Antigens

Analytical, Diagnostic and Therapeutic Techniques and Equipment56

Immunotherapy Immunotherapy, Adoptive Immunotherapy, Active Desensitization, Immunologic Melanoma, Experimental Lymphocyte Activation Monitoring, Immunologic Neoplasms, Experimental Flow Cytometry Clinical Trials as Topic Neoplasm Transplantation Enzyme-Linked Immunosorbent Assay Early Detection of Cancer Combined Modality Therapy Injections, Intralesional Immunization, Passive Genetic Therapy Administration, Sublingual Reverse Transcriptase Polymerase Chain Reaction Sublingual Immunotherapy Molecular Targeted Therapy Immunization Cytotoxicity Tests, Immunologic Adoptive Transfer Transfection Xenograft Model Antitumor Assays Blotting, Western Disease Models, Animal Treatment Outcome Vaccination Models, Immunological Immunomodulation Gene Expression Profiling Immunohistochemistry Transduction, Genetic Survival Analysis Prognosis Tumor Burden Gene Transfer Techniques Coculture Techniques Histocompatibility Testing Survival Rate Immunoenzyme Techniques Sensitivity and Specificity Immunophenotyping Lymphocyte Depletion Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Fluorescent Antibody Technique Follow-Up Studies Cell Separation Polymerase Chain Reaction Neoplasm Staging Prospective Studies Disease-Free Survival Risk

Phenomena and Processes41

Lymphocyte Activation Cytotoxicity, Immunologic Tumor Escape Antigen Presentation Tumor Microenvironment Immune Tolerance Genetic Vectors Amino Acid Sequence Gene Expression Regulation, Neoplastic Immunity, Cellular Cell Proliferation Antibody Specificity Immunologic Surveillance Cross-Priming Immunity Transfection Immunomodulation Base Sequence Transduction, Genetic Time Factors Cell Division Cross Reactions Genetic Predisposition to Disease Phenotype Signal Transduction Gene Expression Apoptosis Cell Differentiation Alleles Mutation Cell Movement Sensitivity and Specificity Antibody-Dependent Cell Cytotoxicity Immunologic Memory Antibody Formation Autoimmunity Protein Binding Drug Resistance, Neoplasm Genotype Risk Cell Survival

Disciplines and Occupations1

Immunohistochemistry

Information Science4

Molecular Sequence Data Amino Acid Sequence Base Sequence Survival Rate

Health Care13

Clinical Trials as Topic Immunization Congresses as Topic Treatment Outcome Vaccination Survival Analysis Survival Rate Sensitivity and Specificity Retrospective Studies Follow-Up Studies Prospective Studies Disease-Free Survival Risk

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Immunotherapy Antigens, Neoplasm Cancer Vaccines Immunotherapy, Adoptive HLA Antigens Antigens Immunotherapy, Active Neoplasms T-Lymphocytes, Cytotoxic Antigens, Bacterial Dendritic Cells Desensitization, Immunologic Antigens, Surface T-Lymphocytes HLA-A2 Antigen Antibodies, Monoclonal HLA-A Antigens Melanoma, Experimental Mice, Inbred C57BL CD8-Positive T-Lymphocytes Antigens, Viral Cell Line, Tumor Melanoma Lymphocyte Activation Mice, Inbred BALB C Cytotoxicity, Immunologic Antigens, CD HLA-A24 Antigen Neoplasm Proteins Tumor Escape Lymphocytes, Tumor-Infiltrating Prostatic Neoplasms Epitopes Interferon-gamma Monitoring, Immunologic Epitopes, T-Lymphocyte Neoplasms, Experimental Flow Cytometry Receptors, Antigen, T-Cell Lung Neoplasms Carcinoembryonic Antigen Colonic Neoplasms Clinical Trials as Topic CTLA-4 Antigen Histocompatibility Antigens Class I Antigens, Tumor-Associated, Carbohydrate HLA-DR Antigens CD4-Positive T-Lymphocytes Neoplasm Transplantation Interleukin-2 Antigen Presentation Tumor Cells, Cultured Enzyme-Linked Immunosorbent Assay Early Detection of Cancer Mice, Transgenic gp100 Melanoma Antigen Antigens, Protozoan MART-1 Antigen Adjuvants, Immunologic Molecular Sequence Data Vaccines, Subunit Antigens, Polyomavirus Transforming Ovarian Neoplasms Antibodies, Neoplasm Antineoplastic Agents Neoplasm Metastasis Receptors, Antigen Combined Modality Therapy Tumor Microenvironment Immune Tolerance Breast Neoplasms Killer Cells, Natural T-Lymphocytes, Regulatory Antigens, CD80 Genetic Vectors Prostate-Specific Antigen Antigen-Presenting Cells Antigens, CD3 Injections, Intralesional Immunization, Passive Genetic Therapy Administration, Sublingual Amino Acid Sequence H-2 Antigens Antigens, Fungal HLA-B Antigens Gene Expression Regulation, Neoplastic Histocompatibility Antigens Class II Vaccines, DNA Immunity, Cellular Mice, Nude Cytokines Reverse Transcriptase Polymerase Chain Reaction Cytokine-Induced Killer Cells Sublingual Immunotherapy Cell Line Antigens, CD40 Melanoma-Specific Antigens Antigens, Helminth Molecular Targeted Therapy

No FAQ available that match "cancer immunotherapy hla a1 antigen"